Entospletinib,Lanraplenib
Kronos Bio,gilead
[]
$kron kronos bio continues to advance investigational syk inhibitors entospletinib and lanraplenib with new preclinical data at eha2022 congress stock news alerts in bio
Over 500 members. DM us for our premium stock alerts.